These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 16343860)
21. Anticholinergic use in hospitalised schizophrenic patients in Belgium. De Hert M; Wampers M; van Winkel R; Peuskens J Psychiatry Res; 2007 Aug; 152(2-3):165-72. PubMed ID: 17445906 [TBL] [Abstract][Full Text] [Related]
22. Predictors of subjective and objective quality of life in outpatients with schizophrenia. Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437 [TBL] [Abstract][Full Text] [Related]
23. A mutual prodrug ester of GABA and perphenazine exhibits antischizophrenic efficacy with diminished extrapyramidal effects. Nudelman A; Gil-Ad I; Shpaisman N; Terasenko I; Ron H; Savitsky K; Geffen Y; Weizman A; Rephaeli A J Med Chem; 2008 May; 51(9):2858-62. PubMed ID: 18363346 [TBL] [Abstract][Full Text] [Related]
24. Effects of switching from conventional antipsychotics to risperidone in Japanese patients with chronic schizophrenia. Nakanishi S; Kunugi H; Murray RM; Nojima S; Ogawa T; Takahashi T Psychiatry Clin Neurosci; 2006 Dec; 60(6):751-7. PubMed ID: 17109710 [TBL] [Abstract][Full Text] [Related]
25. Non-linear complexity measures of heart rate variability in acute schizophrenia. Bär KJ; Boettger MK; Koschke M; Schulz S; Chokka P; Yeragani VK; Voss A Clin Neurophysiol; 2007 Sep; 118(9):2009-15. PubMed ID: 17646130 [TBL] [Abstract][Full Text] [Related]
26. Characterization of the serotonin transporter in lymphocytes and platelets of schizophrenia patients treated with atypical or typical antipsychotics compared to healthy individuals. Barkan T; Peled A; Modai I; Weizman A; Rehavi M Eur Neuropsychopharmacol; 2006 Aug; 16(6):429-36. PubMed ID: 16431091 [TBL] [Abstract][Full Text] [Related]
28. Increased hexosaminidase activity in antipsychotic-induced extrapyramidal side effects: possible association with higher occurrence in bipolar disorder patients. Tunca Z; Resmi H; Ozkara HA; Ciliv G; Celtikci B; Alptekin K; Ozerdem A; Akdede BK; Baykara B; Birsoy B; Ergor G Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1214-20. PubMed ID: 18436361 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of flupentixol and risperidone in chronic schizophrenia with predominantly negative symptoms. Ruhrmann S; Kissling W; Lesch OM; Schmauss M; Seemann U; Philipp M Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1012-22. PubMed ID: 17412473 [TBL] [Abstract][Full Text] [Related]
30. Pharmacological differentiation of classical and novel antipsychotics. Arnt J Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S7-14. PubMed ID: 9690964 [TBL] [Abstract][Full Text] [Related]
31. Side effects of atypical antipsychotics: extrapyramidal symptoms and the metabolic syndrome. Shirzadi AA; Ghaemi SN Harv Rev Psychiatry; 2006; 14(3):152-64. PubMed ID: 16787887 [TBL] [Abstract][Full Text] [Related]
32. CYP2D6 genotype predicts antipsychotic side effects in schizophrenia inpatients: a retrospective matched case-control study. Kobylecki CJ; Jakobsen KD; Hansen T; Jakobsen IV; Rasmussen HB; Werge T Neuropsychobiology; 2009; 59(4):222-6. PubMed ID: 19521114 [TBL] [Abstract][Full Text] [Related]
33. Extrapyramidal side effects with atypical neuroleptics in bipolar disorder. Ghaemi SN; Hsu DJ; Rosenquist KJ; Pardo TB; Goodwin FK Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):209-13. PubMed ID: 16412546 [TBL] [Abstract][Full Text] [Related]
34. Treatment of clozapine-associated tardive dyskinesia. Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744 [No Abstract] [Full Text] [Related]
35. Autonomic nervous system activity and psychiatric severity in schizophrenia. Fujibayashi M; Matsumoto T; Kishida I; Kimura T; Ishii C; Ishii N; Moritani T Psychiatry Clin Neurosci; 2009 Aug; 63(4):538-45. PubMed ID: 19496998 [TBL] [Abstract][Full Text] [Related]
36. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [TBL] [Abstract][Full Text] [Related]
37. Quetiapine reverses altered locomotor activity and tyrosine hydroxylase immunoreactivity in rat caudate putamen following long-term haloperidol treatment. Zhang Y; Xu H; He J; Yan B; Jiang W; Li X; Li XM Neurosci Lett; 2007 Jun; 420(1):66-71. PubMed ID: 17466452 [TBL] [Abstract][Full Text] [Related]
38. Typical and atypical antipsychotics--the misleading dichotomy. Results from the Working Group 'Drugs in Psychiatry' (AGATE). Fischer-Barnicol D; Lanquillon S; Haen E; Zofel P; Koch HJ; Dose M; Klein HE; Neuropsychobiology; 2008; 57(1-2):80-7. PubMed ID: 18515977 [TBL] [Abstract][Full Text] [Related]
39. Serotonergic modulation of dopamine neurotransmission: a mechanism for enhancing therapeutics in schizophrenia. Haleem DJ J Coll Physicians Surg Pak; 2006 Aug; 16(8):556-62. PubMed ID: 16899192 [TBL] [Abstract][Full Text] [Related]
40. Dyskinesia is most centrally situated in an estimated network of extrapyramidal syndrome in Asian patients with schizophrenia: findings from research on Asian psychotropic prescription patterns for antipsychotics. Park SC; Kim GM; Kato TA; Chong MY; Lin SK; Yang SY; Avasthi A; Grover S; Kallivayalil RA; Xiang YT; Chee KY; Tanra AJ; Tan CH; Sim K; Sartorius N; Shinfuku N; Park YC; Inada T Nord J Psychiatry; 2021 Jan; 75(1):9-17. PubMed ID: 32580668 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]